- Home
- GERN vs CABO Comparison
GERN vs CABO Comparison
Compare GERN & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- CABO
- Stock Information
- Founded
- GERN 1990
- CABO 1980
- Country
- GERN United States
- CABO United States
- Employees
- GERN N/A
- CABO N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- CABO Cable & Other Pay Television Services
- Sector
- GERN Health Care
- CABO Telecommunications
- Exchange
- GERN Nasdaq
- CABO Nasdaq
- Market Cap
- GERN 823.0M
- CABO 748.3M
- IPO Year
- GERN 1996
- CABO N/A
- Fundamental
- Price
- GERN $1.38
- CABO $170.51
- Analyst Decision
- GERN Buy
- CABO Hold
- Analyst Count
- GERN 7
- CABO 3
- Target Price
- GERN $3.17
- CABO $171.00
- AVG Volume (30 Days)
- GERN 6.7M
- CABO 110.7K
- Earning Date
- GERN 11-06-2025
- CABO 11-06-2025
- Dividend Yield
- GERN N/A
- CABO 3.46%
- EPS Growth
- GERN N/A
- CABO N/A
- EPS
- GERN N/A
- CABO N/A
- Revenue
- GERN $164,447,000.00
- CABO $1,542,441,000.00
- Revenue This Year
- GERN $175.15
- CABO N/A
- Revenue Next Year
- GERN $56.61
- CABO N/A
- P/E Ratio
- GERN N/A
- CABO N/A
- Revenue Growth
- GERN 11877.20
- CABO N/A
- 52 Week Low
- GERN $1.09
- CABO $117.54
- 52 Week High
- GERN $4.50
- CABO $437.00
- Technical
- Relative Strength Index (RSI)
- GERN 44.59
- CABO 59.38
- Support Level
- GERN $1.26
- CABO $171.38
- Resistance Level
- GERN $1.48
- CABO $180.74
- Average True Range (ATR)
- GERN 0.07
- CABO 6.64
- MACD
- GERN -0.00
- CABO 0.31
- Stochastic Oscillator
- GERN 13.64
- CABO 89.69
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.